DD301724A9 - Mutanten von menschlichem interleukin-3 - Google Patents

Mutanten von menschlichem interleukin-3 Download PDF

Info

Publication number
DD301724A9
DD301724A9 DD90343414A DD34341490A DD301724A9 DD 301724 A9 DD301724 A9 DD 301724A9 DD 90343414 A DD90343414 A DD 90343414A DD 34341490 A DD34341490 A DD 34341490A DD 301724 A9 DD301724 A9 DD 301724A9
Authority
DD
German Democratic Republic
Prior art keywords
amino acids
biologically active
deletion
mutants
active polypeptide
Prior art date
Application number
DD90343414A
Other languages
German (de)
English (en)
Inventor
Lambertus Ch J Dorssers
Robert W Van Leen
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26121243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DD301724(A9) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Priority to DD90343414A priority Critical patent/DD301724A9/de
Publication of DD301724A9 publication Critical patent/DD301724A9/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DD90343414A 1989-08-14 1990-08-13 Mutanten von menschlichem interleukin-3 DD301724A9 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DD90343414A DD301724A9 (de) 1989-08-14 1990-08-13 Mutanten von menschlichem interleukin-3

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP89202082 1989-08-14
EP89202331 1989-09-14
DD90343414A DD301724A9 (de) 1989-08-14 1990-08-13 Mutanten von menschlichem interleukin-3

Publications (1)

Publication Number Publication Date
DD301724A9 true DD301724A9 (de) 1993-08-12

Family

ID=26121243

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90343414A DD301724A9 (de) 1989-08-14 1990-08-13 Mutanten von menschlichem interleukin-3

Country Status (17)

Country Link
EP (2) EP0810285A3 (fr)
JP (1) JP3192416B2 (fr)
AT (1) ATE154638T1 (fr)
AU (1) AU636641B2 (fr)
CA (1) CA2023246C (fr)
DD (1) DD301724A9 (fr)
DE (1) DE69030937T2 (fr)
DK (1) DK0413383T3 (fr)
ES (1) ES2106017T3 (fr)
FI (1) FI105192B (fr)
GR (1) GR3024679T3 (fr)
HU (1) HUT54411A (fr)
IE (2) IE902921A1 (fr)
IL (1) IL95350A0 (fr)
NO (1) NO301481B1 (fr)
NZ (1) NZ234869A (fr)
PT (1) PT94992B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0609280B1 (fr) * 1991-10-07 1999-04-21 Medvet Science Pty. Ltd. Variants d'interleukine-3 humains
US6403076B1 (en) 1992-11-24 2002-06-11 S. Christopher Bauer Compositions for increasing hematopoiesis with interleukin-3 mutants
EP1361273A3 (fr) * 1992-11-24 2004-02-11 G.D. Searle & Co. Mutants de l'interleukine-3 (iL-3) avec de multiples mutations
US6153183A (en) * 1992-11-24 2000-11-28 G. D. Searle & Company Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production
US6413509B1 (en) 1992-11-24 2002-07-02 S. Christopher Bauer Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors
US6361977B1 (en) * 1992-11-24 2002-03-26 S. Christopher Bauer Methods of using multivariant IL-3 hematopoiesis fusion protein
US5772992A (en) * 1992-11-24 1998-06-30 G.D. Searle & Co. Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
US6361976B1 (en) 1992-11-24 2002-03-26 S. Christopher Bauer Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US5501962A (en) * 1993-06-21 1996-03-26 G. D. Searle & Co. Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same
EP0715633A4 (fr) * 1993-07-28 1997-11-19 Medvet Science Pty Ltd Antagonistes de facteurs de croissance hematopoietique
US6465616B1 (en) 1994-04-08 2002-10-15 Bresagen Limited Interleukin-5 antagonist
US6017523A (en) * 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
US6270758B1 (en) 1998-10-08 2001-08-07 Duke University Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects
JP4735670B2 (ja) * 2008-06-11 2011-07-27 富士ゼロックス株式会社 プリント基板および画像処理装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR871029B (en) 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors
NZ222939A (en) 1986-12-16 1991-03-26 Gist Brocades Nv Human interleukin-3, production using genetic engineering methods, antibodies to human interleukin-3 and screening of dna library with 3' untranslated region
EP0790307A1 (fr) 1986-12-16 1997-08-20 Gist-Brocades B.V. Clonage et expression moléculaire de IL-3 humain
AU1496688A (en) * 1987-01-20 1988-08-10 Immunex Corporation Human interleukin-3 proteins
US4743264A (en) * 1987-02-05 1988-05-10 Sherva Parker Carole J External prothesis with magnetic field
OA09736A (en) * 1987-02-18 1993-11-30 Schering Biotech Corp "Human interleukin-3 and muteins thereof".

Also Published As

Publication number Publication date
IL95350A0 (en) 1991-06-30
IE980055A1 (en) 2000-02-23
DE69030937D1 (de) 1997-07-24
DK0413383T3 (da) 1997-07-07
NO301481B1 (no) 1997-11-03
PT94992A (pt) 1991-04-18
HUT54411A (en) 1991-02-28
EP0810285A2 (fr) 1997-12-03
ES2106017T3 (es) 1997-11-01
ATE154638T1 (de) 1997-07-15
FI105192B (fi) 2000-06-30
NZ234869A (en) 1991-12-23
EP0413383A1 (fr) 1991-02-20
CA2023246C (fr) 2002-02-19
AU6096090A (en) 1991-02-14
JP3192416B2 (ja) 2001-07-30
CA2023246A1 (fr) 1991-02-15
FI903996A0 (fi) 1990-08-13
JPH0420295A (ja) 1992-01-23
NO903544D0 (no) 1990-08-13
EP0413383B1 (fr) 1997-06-18
PT94992B (pt) 1997-09-30
IE902921A1 (en) 1991-02-27
DE69030937T2 (de) 1997-10-09
EP0810285A3 (fr) 1998-07-08
GR3024679T3 (en) 1997-12-31
AU636641B2 (en) 1993-05-06
NO903544L (no) 1991-02-15

Similar Documents

Publication Publication Date Title
DE3856238T2 (de) DNA, die für Proteine kodiert, die menschliches IL-1 binden
DE69007975T2 (de) Fusionsprotein bestehend aus gm-csf und il-3.
DE3789859T2 (de) Formen des Koloniestimulierungsfaktors 1.
DE69014162T2 (de) Morphogenetisches Knochenprotein.
DE3750113T2 (de) Für menschliche "Colony-stimulating"-Faktoren kodierendes Gen.
JP3115561B2 (ja) 白血球を増加させるための医薬組成物の製造方法
DE3689391T2 (de) Rekombinanter koloniestimulierender faktor-1.
DE69033301T2 (de) Erythropoietin- Analoge
DE3888379T2 (de) Leukämie hemmender Faktor.
DE68916537T3 (de) Herstellung eines insulinähnlichen, wachstümsfaktor bindenden proteins.
DE69636938T2 (de) HYBRID AUS INTERFERON-alpha UND IMMUNGLOBULIN Fc-FRAGMENT VERBUNDEN DURCH EIN NICHT IMMUNOGENES PEPTID
DE69031997T2 (de) TNF(Tumor Necrosis Factor)-Inhibitor und Verfahren zur Herstellung
DE69033700T2 (de) Il-11 aus säugetier
DE69836217T2 (de) Chimäres lösliches interleukin-6 rezeptor/ligand protein, analoge und verwendungen
DE3750451T2 (de) Rekombinanter menschlicher endothelzellenwachstumsfaktor.
DE68926859T2 (de) Natürlicher killerzellen-stimulationsfaktor
DE69027031T2 (de) Nicht glycosierte proteine, analoge des menschlichen interleukin-3
EP0769020B1 (fr) Nouvelles proteines mutantes de l'il-4 humaine utilisees comme antagonistes ou agonistes partiels de l'interleukine humaine 4
DD301724A9 (de) Mutanten von menschlichem interleukin-3
DE3751677T2 (de) Neue familie von primat-hämatopoietischen wachstumsfaktoren
DE3851035T2 (de) Interleukin-7.
DE69131426T2 (de) Neue wasserlösliche polypeptide mit hoher affinität für alpha- und beta- interferone
US5516512A (en) N- and C-terminal truncation and deletion mutants of human interleukin-3
DE69131421T2 (de) Für den rezeptor des granulozytenkolonie stimulierenden faktors kodierende dns
DE69636052T2 (de) Mpl-liganden analoga

Legal Events

Date Code Title Description
NAA Public notice for inspection of patent application
A9 Laid open application accord. to par. 10.3 extension act